My work focuses on finding less invasive yet more effective surgical procedures for patients with breast cancer and soft tissue sarcomas. I am a translational research investigator and work with Dr. Khandan Keyomarsi on developing novel treatment strategies involving agents that target cell cycle regulation. The lab works on low molecular weight cyclin E as an important prognostic marker of breast cancer. Ongoing studies are investigating the underlying mechanisms of resistance to standard of care therapeutics and metastasis for ER positive breast cancer. The team has also identified a novel combination treatment strategy using cell cycle checkpoint defects in soft tissue sarcoma.

I served as the director of the American College of Surgeons (ACS) Cancer Research Program, and currently serves as the Vice Chair of the ACS Cancer Surgery Standards Program. I am the President of the American Radium Society, President of the Society of Surgical Oncology and Recorder of the American Surgical Association.